Global Synthetic Stem Cells Market – Industry Analysis and Forecast (2018-2026), by Application and Region.

Global Synthetic Stem Cells Market – Industry Analysis and Forecast (2018-2026), by Application and Region.

Market Scenario

Global Synthetic Stem Cells Market was valued at US$ 7.97 Mn in 2017, and is expected to reach at US$ 37Mn by 2026, at CAGR of 22.62% during forecast period. Global Synthetic Stem Cells Market Different Applications of adult stem cells in regenerative medicines have made huge attention and interest among doctors and hospitals at large. There is huge scope for stem cells in the treatment of cardiology and neurology. • Explain and define synthetic stem cells market • Forecast the synthetic stem cells market, by region • Forecast the synthetic stem cells market, by application • Detailed research of factors influencing on synthetic stem cells market (drivers, restraints, opportunities and challenges) • Critical analysis of industry trends, prospects and contribution to the synthetic stem cells market • Analysis of synthetic stem cells market for stake holders • Forecasting of market size by different geographic segment of synthetic stem cells market. Driving factors that influence Synthetic Stem Cell Market include ethical values of embryonic stem cells, the risk of tumour formation and risk of rejection due to immune to natural stem cells. Stem cell work by promoting endogenous healing; that is, they heal damaged parts of tissue in repairing itself by secreting paracrine factors. While stem cell treatment is more effective, they are also linked with the same risks of both tumour growth and immune rejection. It is the major driving force for synthetic stem cells. The largest market share of the synthetic stem cells market is occupied by cardiovascular diseases, the fact is first synthetic stem cells was invented to cure cardiac tissue. North America has a large market share of synthetic stem cells in the region. The Asia Pacific and European region have almost equal market share. Rest of the world have least market share as compared to the other regions. Key players operating in the Synthetic stem cells market are Sangamo Therapeutics, Athersys, Pluristem Therapeutics, Cellular Biomedicine Group, Vericel, BrainstormCell Therapeutics, Caladrius Biosciences, Cytori Therapeutics, Cesca Therapeutics, VistaGen Therapeutics. The report covers total market for synthetic stem cells has been analysed based on the Porter's five forces model. The impact of the different market factors, such as drivers, restraints, and opportunities, challenges key issues SWOT analysis, and technology forecasting is also illustrated in the report.

Scope of Global Synthetic Stem Cells Market:

Global Synthetic Stem Cells Market, by Application:

• Cardiovascular Disease • Neurological Disorders • Cancer • Diabetes • Gastrointestinal • Musculoskeletal Disorders

Global Synthetic Stem Cells Market, by Region:

• North America • Europe • Middle East & Africa • Asia Pacific • South America

Key Players Operating In Global Synthetic Stem Cells Market:

• Sangamo Therapeutics • Athersys • Pluristem Therapeutics • Cellular Biomedicine Group • Vericel • BrainstormCell Therapeutics • Caladrius Biosciences • Cytori Therapeutics • Cesca Therapeutics • VistaGen Therapeutics Global Zinc Oxide Market

Table of Contents

Global Synthetic Stem Cells Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Synthetic Stem Cells Size, by Market Value (US$ Mn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Synthetic Stem Cells Market Analysis and Forecast 6.1. Global Synthetic Stem Cells Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Synthetic Stem Cells Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Synthetic Stem Cells Market Value Share Analysis, by Application 7.4. Global Synthetic Stem Cells Market Size (US$ Mn) Forecast, by Application 7.5. Global Synthetic Stem Cells Market Analysis, by Application 7.6. Global Synthetic Stem Cells Market Attractiveness Analysis, by Application 8. Global Synthetic Stem Cells Market Analysis, by Region 8.1. Global Synthetic Stem Cells Market Value Share Analysis, by Region 8.2. Global Synthetic Stem Cells Market Size (US$ Mn) Forecast, by Region 8.3. Global Synthetic Stem Cells Market Attractiveness Analysis, by Region 9. North America Synthetic Stem Cells Market Analysis 9.1. Key Findings 9.2. North America Synthetic Stem Cells Market Overview 9.3. North America Synthetic Stem Cells Market Value Share Analysis, by Application 9.4. North America Synthetic Stem Cells Market Forecast, by Application 9.4.1. Cardiovascular Disease 9.4.2. Neurological Disorders 9.4.3. Cancer 9.4.4. Gastrointestinal 9.4.5. Musculoskeletal Disorders 9.5. North America Synthetic Stem Cells Market Value Share Analysis, by Country 9.6. North America Synthetic Stem Cells Market Forecast, by Country 9.6.1. U.S. 9.6.2. Canada 9.7. North America Synthetic Stem Cells Market Analysis, by Country 9.8. U.S. Synthetic Stem Cells Market Forecast, by Application 9.8.1. Cardiovascular Disease 9.8.2. Neurological Disorders 9.8.3. Cancer 9.8.4. Gastrointestinal 9.8.5. Musculoskeletal Disorders 9.9. Canada Synthetic Stem Cells Market Forecast, by Application 9.9.1. Cardiovascular Disease 9.9.2. Neurological Disorders 9.9.3. Cancer 9.9.4. Gastrointestinal 9.9.5. Musculoskeletal Disorders 9.10. North America Synthetic Stem Cells Market Attractiveness Analysis 9.10.1. By Application 9.11. PEST Analysis 9.12. Key Trends 9.13. Key Developments 10. Europe Synthetic Stem Cells Market Analysis 10.1. Key Findings 10.2. Europe Synthetic Stem Cells Market Overview 10.3. Europe Synthetic Stem Cells Market Value Share Analysis, by Application 10.4. Europe Synthetic Stem Cells Market Value Share Analysis, by Application 10.5. Europe Synthetic Stem Cells Market Forecast, by Application 10.5.1. Cardiovascular Disease 10.5.2. Neurological Disorders 10.5.3. Cancer 10.5.4. Gastrointestinal 10.5.5. Musculoskeletal Disorders 10.6. Europe Synthetic Stem Cells Market Value Share Analysis, by Country 10.7. Europe Synthetic Stem Cells Market Forecast, by Country 10.7.1. Germany 10.7.2. U.K. 10.7.3. France 10.7.4. Italy 10.7.5. Spain 10.7.6. Rest of Europe 10.8. Europe Synthetic Stem Cells Market Analysis, by Country 10.9. Germany Synthetic Stem Cells Market Forecast, by Application 10.9.1. Cardiovascular Disease 10.9.2. Neurological Disorders 10.9.3. Cancer 10.9.4. Gastrointestinal 10.9.5. Musculoskeletal Disorders 10.10. U.K. Synthetic Stem Cells Market Forecast, by Application 10.10.1. Cardiovascular Disease 10.10.2. Neurological Disorders 10.10.3. Cancer 10.10.4. Gastrointestinal 10.10.5. Musculoskeletal Disorders 10.11. France Synthetic Stem Cells Market Forecast, by Application 10.11.1. Cardiovascular Disease 10.11.2. Neurological Disorders 10.11.3. Cancer 10.11.4. Gastrointestinal 10.11.5. Musculoskeletal Disorders 10.12. Italy Synthetic Stem Cells Market Forecast, by Application 10.12.1. Cardiovascular Disease 10.12.2. Neurological Disorders 10.12.3. Cancer 10.12.4. Gastrointestinal 10.12.5. Musculoskeletal Disorders 10.13. Spain Synthetic Stem Cells Market Forecast, by Application 10.13.1. Cardiovascular Disease 10.13.2. Neurological Disorders 10.13.3. Cancer 10.13.4. Gastrointestinal 10.13.5. Musculoskeletal Disorders 10.14. Rest of Europe Synthetic Stem Cells Market Forecast, by Application 10.14.1. Cardiovascular Disease 10.14.2. Neurological Disorders 10.14.3. Cancer 10.14.4. Gastrointestinal 10.14.5. Musculoskeletal Disorders 10.15. Europe Synthetic Stem Cells Market Attractiveness Analysis 10.15.1. By Application 10.16. PEST Analysis 10.17. Key Trends 10.18. Key Developments 11. Asia Pacific Synthetic Stem Cells Market Analysis 11.1. Key Findings 11.2. Asia Pacific Synthetic Stem Cells Market Overview 11.3. Asia Pacific Synthetic Stem Cells Market Value Share Analysis, by Application 11.4. Asia Pacific Synthetic Stem Cells Market Forecast, by Application 11.4.1. Cardiovascular Disease 11.4.2. Neurological Disorders 11.4.3. Cancer 11.4.4. Gastrointestinal 11.4.5. Musculoskeletal Disorders 11.5. Asia Pacific Synthetic Stem Cells Market Value Share Analysis, by Country 11.6. Asia Pacific Synthetic Stem Cells Market Forecast, by Country 11.6.1. China 11.6.2. India 11.6.3. Japan 11.6.4. ASEAN 11.6.5. Rest of Asia Pacific 11.7. Asia Pacific Synthetic Stem Cells Market Analysis, by Country 11.8. China Synthetic Stem Cells Market Forecast, by Application 11.8.1. Cardiovascular Disease 11.8.2. Neurological Disorders 11.8.3. Cancer 11.8.4. Gastrointestinal 11.8.5. Musculoskeletal Disorders 11.9. India Synthetic Stem Cells Market Forecast, by Application 11.9.1. Cardiovascular Disease 11.9.2. Neurological Disorders 11.9.3. Cancer 11.9.4. Gastrointestinal 11.9.5. Musculoskeletal Disorders 11.10. Japan Synthetic Stem Cells Market Forecast, by Application 11.10.1. Cardiovascular Disease 11.10.2. Neurological Disorders 11.10.3. Cancer 11.10.4. Gastrointestinal 11.10.5. Musculoskeletal Disorders 11.11. ASEAN Synthetic Stem Cells Market Forecast, by Application 11.11.1. Cardiovascular Disease 11.11.2. Neurological Disorders 11.11.3. Cancer 11.11.4. Gastrointestinal 11.11.5. Musculoskeletal Disorders 11.12. Rest of Asia Pacific Synthetic Stem Cells Market Forecast, by Application 11.12.1. Cardiovascular Disease 11.12.2. Neurological Disorders 11.12.3. Cancer 11.12.4. Gastrointestinal 11.12.5. Musculoskeletal Disorders 11.13. Asia Pacific Synthetic Stem Cells Market Attractiveness Analysis 11.13.1. By Application 11.14. PEST Analysis 11.15. Key Trends 11.16. Key Developments 12. Middle East & Africa Synthetic Stem Cells Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Synthetic Stem Cells Market Overview 12.3. Middle East & Africa Synthetic Stem Cells Market Value Share Analysis, by Application 12.4. Middle East & Africa Synthetic Stem Cells Market Forecast, by Application 12.4.1. Cardiovascular Disease 12.4.2. Neurological Disorders 12.4.3. Cancer 12.4.4. Gastrointestinal 12.4.5. Musculoskeletal Disorders 12.5. Middle East & Africa Synthetic Stem Cells Market Value Share Analysis, by Country 12.6. Middle East & Africa Synthetic Stem Cells Market Forecast, by Country 12.6.1. GCC 12.6.2. South Africa 12.6.3. Rest of Middle East & Africa 12.7. Middle East & Africa Synthetic Stem Cells Market Analysis, by Country 12.8. GCC Synthetic Stem Cells Market Forecast, by Application 12.8.1. Cardiovascular Disease 12.8.2. Neurological Disorders 12.8.3. Cancer 12.8.4. Gastrointestinal 12.8.5. Musculoskeletal Disorders 12.9. South Africa Synthetic Stem Cells Market Forecast, by Application 12.9.1. Cardiovascular Disease 12.9.2. Neurological Disorders 12.9.3. Cancer 12.9.4. Gastrointestinal 12.9.5. Musculoskeletal Disorders 12.10. Rest of Middle East & Africa Synthetic Stem Cells Market Forecast, by Application 12.10.1. Cardiovascular Disease 12.10.2. Neurological Disorders 12.10.3. Cancer 12.10.4. Gastrointestinal 12.10.5. Musculoskeletal Disorders 12.11. Middle East & Africa Synthetic Stem Cells Market Attractiveness Analysis 12.11.1. By Application 12.12. PEST Analysis 12.13. Key Trends 12.14. Key Developments 13. South America Synthetic Stem Cells Market Analysis 13.1. Key Findings 13.2. South America Synthetic Stem Cells Market Overview 13.3. South America Synthetic Stem Cells Market Value Share Analysis, by Application 13.4. South America Synthetic Stem Cells Market Forecast, by Application 13.4.1. Cardiovascular Disease 13.4.2. Neurological Disorders 13.4.3. Cancer 13.4.4. Gastrointestinal 13.4.5. Musculoskeletal Disorders 13.5. South America Synthetic Stem Cells Market Value Share Analysis, by Country 13.6. South America Synthetic Stem Cells Market Forecast, by Country 13.6.1. Brazil 13.6.2. Mexico 13.6.3. Rest of South America 13.7. South America Synthetic Stem Cells Market Analysis, by Country 13.8. Brazil Synthetic Stem Cells Market Forecast, by Application 13.8.1. Cardiovascular Disease 13.8.2. Neurological Disorders 13.8.3. Cancer 13.8.4. Gastrointestinal 13.8.5. Musculoskeletal Disorders 13.9. Mexico Synthetic Stem Cells Market Forecast, by Application 13.9.1. Cardiovascular Disease 13.9.2. Neurological Disorders 13.9.3. Cancer 13.9.4. Gastrointestinal 13.9.5. Musculoskeletal Disorders 13.10. Rest of South America Synthetic Stem Cells Market Forecast, by Application 13.10.1. Cardiovascular Disease 13.10.2. Neurological Disorders 13.10.3. Cancer 13.10.4. Gastrointestinal 13.10.5. Musculoskeletal Disorders 13.11. South America Synthetic Stem Cells Market Attractiveness Analysis 13.11.1. By Application 13.12. PEST Analysis 13.13. Key Trends 13.14. Key Developments 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 14.2.2. New Product Launches and Product Enhancements 14.2.3. Market Consolidation 14.2.3.1. M&A by Regions, Investment and Applications 14.2.3.2. M&A Key Players, Forward Integration and Backward Integration 14.3. Company Profiles: Key Players 14.3.1. Sangamo Therapeutics 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Product Portfolio 14.3.1.4. Business Strategy 14.3.1.5. Recent Developments 14.3.1.6. Manufacturing Footprints 14.3.2. Athersys 14.3.3. Pluristem Therapeutics 14.3.4. Cellular Biomedicine Group 14.3.5. Vericel 14.3.6. BrainstormCell Therapeutics 14.3.7. Caladrius Biosciences 14.3.8. Cytori Therapeutics 14.3.9. Cesca Therapeutics 14.3.10. VistaGen Therapeutics 15. Primary key insights

About This Report

Report ID22622
Published Date
Contact Us
Call Now